Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases

被引：0
|
作者：
Parth Shah
机构：
[1] ObvioHealth,
来源：
Current Cardiology Reports | 2018年 / 20卷
关键词：
Alirocumab; Evolocumab; PCSK9; Cardiovascular; Cholesterol; Lipoprotein (a);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] PCSK9 inhibitors
    Gencer, Baris
    Lambert, Gilles
    Mach, Francois
    SWISS MEDICAL WEEKLY, 2015, 145
  • [22] EVALUATING THE IMPACT OF PCSK9 INHIBITORS ON CARDIOVASCULAR DISEASE
    Karcher, H.
    Wiecek, W.
    Casciano, R.
    Coeytaux, E.
    Bixer, S.
    Amzal, B.
    Abenhaim, L.
    VALUE IN HEALTH, 2017, 20 (09) : A630 - A630
  • [23] Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?
    Giugliano, Robert P.
    Sabatine, Marc S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (24) : 2638 - 2651
  • [24] Do PCSK9 inhibitors reduce cardiovascular events?
    Kolber, Michael R.
    Nickonchuk, Tony
    Turgeon, Ricky
    CANADIAN FAMILY PHYSICIAN, 2018, 64 (09) : 669 - 669
  • [25] PCSK9 inhibitors: A new era in stroke prevention?
    Castilla-Guerra, Luis
    Fernandez-Moreno, M. C.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : E44 - E44
  • [26] Efficacy and Safety of PCSK9 Inhibitors in Stroke Prevention
    Moustafa, Bayan
    Testai, Fernando
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (11):
  • [27] Cost-effectiveness analysis of PCSK9 inhibitors in cardiovascular diseases: a systematic review
    Samad Azari
    Aziz Rezapour
    Negar Omidi
    Vahid Alipour
    Masoud Behzadifar
    Hossein Safari
    Masih Tajdini
    Nicola Luigi Bragazzi
    Heart Failure Reviews, 2020, 25 : 1077 - 1088
  • [28] Cost-effectiveness analysis of PCSK9 inhibitors in cardiovascular diseases: a systematic review
    Azari, Samad
    Rezapour, Aziz
    Omidi, Negar
    Alipour, Vahid
    Behzadifar, Masoud
    Safari, Hossein
    Tajdini, Masih
    Bragazzi, Nicola Luigi
    HEART FAILURE REVIEWS, 2020, 25 (06) : 1077 - 1088
  • [29] PCSK9 inhibitors in the prevention of cardiovascular disease (vol 42, pg 405, 2016)
    Latimer, James
    Batty, Jonathan A.
    Neely, R. Dermot G.
    Kunadian, Vijay
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 42 (03) : 420 - 420
  • [30] PCSK9 Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
    Zhuravleva, Marina, V
    Prokofievl, Alexey B.
    Shikh, Evgenia, V
    Serebrova, Svetlana Yu
    Gorodetskaya, Galina, I
    Demchenkova, Elena Yu
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (04) : 644 - 653
12345